BCR antibody (AA 1042-1243)
-
- Target See all BCR Antibodies
- BCR (Breakpoint Cluster Region (BCR))
-
Binding Specificity
- AA 1042-1243
-
Reactivity
- Human
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This BCR antibody is un-conjugated
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC)
- Specificity
- The antibody is a rabbit polyclonal antibody raised against BCR. It has been selected for its ability to recognize BCR in immunohistochemical staining and western blotting.
- Purification
- Antigen-specific affinity chromatography
- Immunogen
- BCR (Arg1042-Val1243)
- Isotype
- IgG
- Top Product
- Discover our top product BCR Primary Antibody
-
-
- Application Notes
-
- Western blotting: 1:50-400 Immunocytochemistry in formalin fixed cells: 1:50-500 Immunohistochemistry in formalin fixed frozen section: 1:50-500 Immunohistochemistry in paraffin section: 1:10-100 Enzyme-linked Immunosorbent Assay: 1:100-1:5000 Optimal working dilutions must be determined by end user.
- Comment
-
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
-
- Target
- BCR (Breakpoint Cluster Region (BCR))
- Abstract
- BCR Products
- Synonyms
- si:dkey-83d9.7 antibody, zK83D9.7 antibody, BCR antibody, ALL antibody, BCR1 antibody, CML antibody, D22S11 antibody, D22S662 antibody, PHL antibody, 5133400C09Rik antibody, AI561783 antibody, AI853148 antibody, mKIAA3017 antibody, breakpoint cluster region antibody, BCR, RhoGEF and GTPase activating protein antibody, bcr antibody, BCR antibody, Bcr antibody
- Background
- Alternative Names: ALL, BCR/FGFR1, BCR1, CML, FGFR1/BCR, PHL, Renal carcinoma antigen NY-REN-26
- Pathways
- Regulation of Leukocyte Mediated Immunity, Platelet-derived growth Factor Receptor Signaling
-